| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Yu Yong | GNLX | SVP, Clinical Development | Nov 17, 2025 | Sell | $5.37 | 973 | $5,224.43 | 145,844 | |
| Yu Yong | GNLX | SVP, Clinical Development | Aug 21, 2025 | Sell | $3.36 | 3,219 | $10,807.47 | 145,844 | |
| Yu Yong | GNLX | VP, Clinical Trial Operations | May 12, 2025 | Sell | $2.92 | 5,579 | $16,290.68 | 145,844 | |
| Yu Yong | GNLX | VP, Clinical Trial Operations | Feb 19, 2024 | Sell | $2.12 | 6,849 | $14,519.88 | 145,844 | |
| Yu Yong | GNLX | VP, Clinical Trial Operations | Dec 15, 2023 | Sell | $13.56 | 32,535 | $428,179.82 | 145,844 | |
| Yu Yong | GNLX | VP, Clinical Trial Operations | Dec 7, 2023 | Sell | $11.85 | 36,800 | $435,995.36 | 145,844 | |
| Yu Yong | GNLX | VP, Clinical Trial Operations | Nov 17, 2023 | Sell | $12.15 | 18,135 | $210,430.99 | 145,844 | |
| Yu Yong | GNLX | VP, Clinical Trial Operations | Oct 24, 2023 | Sell | $19.11 | 5,200 | $99,351.20 | 145,844 |